secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0000950170-22-011751
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics stockholders elect three directors, ratify EY as auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Shareholders elected Heather Berger, Rodney Lappe, and John Schmid as Class I directors to serve until 2025.
- Votes for Berger: 49,858,607; for Lappe: 49,543,074; for Schmid: 49,344,059; with ~1.94M broker non-votes each.
- Ratification of Ernst & Young as independent auditor for FY2022 passed with 53,181,814 votes for, 542 against, 36 abstentions.
- Meeting held June 15, 2022; 55,781,681 shares outstanding and entitled to vote as of record date April 18, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/0000950170-22-011751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/dsgn-20220615.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer